Compounders Research Compare

Lucid Diagnostics Inc.(LUCD)

Medical - Devices · New York City, NY

$0.59-0.00 (-0.59%)

Delayed quote: Oct 6, 2026, 10:23 AM EDT

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.

New York City, NY

82 employees

www.luciddx.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Lishan Aklog

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T14:27:13.358Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:27:13.358Z.

Quote observation: 2026-10-06T14:23:16.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.4661
Quote price: 0.5898

FMP input reference: a3d1fbdfc20658083391a22a35257b501cad1354629c31eed1b40f8a69f1a870

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

LUCD Earnings Yield Metrics

EARNINGS YIELD

N/A

LUCD Competitors' Earnings Yield

Lucid Diagnostics Inc.

Current

Market Cap

$112.52M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Coya Therapeutics, Inc.

Market Cap

$112.36M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cumberland Pharmaceuticals Inc.

Market Cap

$110.73M

Earnings Yield

N/A

TTM Avg

0.32%

3Y Avg

0.91%

5Y Avg

2.50%

MaxCyte, Inc.

Market Cap

$114.62M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Apyx Medical Corporation

Market Cap

$109.91M

Earnings Yield

N/A

TTM Avg

26.36%

3Y Avg

26.36%

5Y Avg

26.36%

BGM Group Ltd.

Market Cap

$109.24M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aardvark Therapeutics, Inc. Common Stock

Market Cap

$109.20M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Genelux Corporation

Market Cap

$114.79M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Foghorn Therapeutics Inc.

Market Cap

$109.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Caribou Biosciences, Inc.

Market Cap

$116.54M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Lucid Diagnostics Inc. (LUCD)	$112.52M	N/A	N/A	N/A	N/A
Coya Therapeutics, Inc. (COYA)vs ›	$112.36M	N/A	N/A	N/A	N/A
Cumberland Pharmaceuticals Inc. (CPIX)vs ›	$110.73M	N/A	0.32%	0.91%	2.50%
MaxCyte, Inc. (MXCT)vs ›	$114.62M	N/A	N/A	N/A	N/A
Apyx Medical Corporation (APYX)vs ›	$109.91M	N/A	26.36%	26.36%	26.36%
BGM Group Ltd. (BGM)vs ›	$109.24M	N/A	N/A	N/A	N/A
Aardvark Therapeutics, Inc. Common Stock (AARD)vs ›	$109.20M	N/A	N/A	N/A	N/A
Genelux Corporation (GNLX)vs ›	$114.79M	N/A	N/A	N/A	N/A
Foghorn Therapeutics Inc. (FHTX)vs ›	$109.21M	N/A	N/A	N/A	N/A
Caribou Biosciences, Inc. (CRBU)vs ›	$116.54M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics